These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23989017)

  • 21. Breast Cancer: Genetics and Risk Assessment.
    Tejada-Bergés T
    Clin Obstet Gynecol; 2016 Dec; 59(4):673-687. PubMed ID: 27749364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The utility of genetics in inherited cancer.
    Winship IM; Tucker K
    Med J Aust; 2013 Nov; 199(10):644. PubMed ID: 24237079
    [No Abstract]   [Full Text] [Related]  

  • 23. Hereditary breast and ovarian cancer syndrome: should we test adolescents?
    Seeber B; Driscoll DA
    J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):161-7. PubMed ID: 15125901
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic testing by cancer site: breast.
    Shannon KM; Chittenden A
    Cancer J; 2012; 18(4):310-9. PubMed ID: 22846731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
    Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
    Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic predisposition testing for cancer: effects on families' lives.
    MacDonald DJ
    Holist Nurs Pract; 1998 Apr; 12(3):9-19. PubMed ID: 9624953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic testing for cancer predisposition.
    Eng C; Hampel H; de la Chapelle A
    Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary breast cancer syndromes and clinical implications.
    Majdak-Paredes EJ; Fatah F
    J Plast Reconstr Aesthet Surg; 2009 Feb; 62(2):181-9. PubMed ID: 19027378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.
    Paluch-Shimon S; Cardoso F; Sessa C; Balmana J; Cardoso MJ; Gilbert F; Senkus E;
    Ann Oncol; 2016 Sep; 27(suppl 5):v103-v110. PubMed ID: 27664246
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?
    Stoppa-Lyonnet D; Caligo M; Eccles D; Evans DG; Haites NE; Hodgson NS; Møller P; Morrison PJ; Steel CM; Vasen HF; Chang-Claude J
    Dis Markers; 1999 Oct; 15(1-3):67-8. PubMed ID: 10595254
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening for cancer predisposition.
    Markham AF; Coletta PL; Robinson PA; Clissold P; Taylor GR; Carr IM; Meredith DM
    Eur J Cancer; 1994; 30A(13):2015-29. PubMed ID: 7734216
    [No Abstract]   [Full Text] [Related]  

  • 32. [DNA microarrays in the clinic?].
    Jordan B
    Med Sci (Paris); 2007 Feb; 23(2):210-4. PubMed ID: 17291433
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
    Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
    Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.
    Kamps R; Brandão RD; Bosch BJ; Paulussen AD; Xanthoulea S; Blok MJ; Romano A
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosocial aspects of familial breast and ovarian cancer: psychological guidelines for genetic testing.
    Decruyenaere M; Evers-Kiebooms G; Claes E; Denayer L; Welkenhuysen M; Legius E; Demyttenaere K
    Dis Markers; 1999 Oct; 15(1-3):152-3. PubMed ID: 10595271
    [No Abstract]   [Full Text] [Related]  

  • 36. Hereditary breast and ovarian cancer: new genes in confined pathways.
    Nielsen FC; van Overeem Hansen T; Sørensen CS
    Nat Rev Cancer; 2016 Sep; 16(9):599-612. PubMed ID: 27515922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer genetics services in the UK.
    Hodgson SV
    Dis Markers; 1999 Oct; 15(1-3):44-5. PubMed ID: 10595251
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic counseling for breast cancer.
    Clark S; Iglehart JD
    Adv Surg; 1999; 33():199-215. PubMed ID: 10572568
    [No Abstract]   [Full Text] [Related]  

  • 39. Cancer genetics services in Europe.
    Hodgson S; Milner B; Brown I; Bevilacqua G; Chang-Claude J; Eccles D; Evans G; Gregory H; Møller P; Morrison P; Steel M; Stoppa-Lyonnet D; Vasen H; Haites N
    Dis Markers; 1999 Oct; 15(1-3):3-13. PubMed ID: 10595245
    [No Abstract]   [Full Text] [Related]  

  • 40. Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment.
    Kurian AW; Kingham KE; Ford JM
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):23-33. PubMed ID: 25502425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.